{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:28:22Z","timestamp":1740144502348,"version":"3.37.3"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:00:00Z","timestamp":1506038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Vitiligo Research Foundation","award":["(VRF11102015\/1)"],"award-info":[{"award-number":["(VRF11102015\/1)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To assess the sociodemographic data and clinical information of outpatients affected by vitiligo in the northeast of China, vitiligo patients or guardians who presented to the clinic were invited to participate in an exploratory questionnaire. The questionnaire consisted of two sections related to vitiligo, including sociodemographic data and clinical information. A total of 983 vitiligo patients answered the questionnaire. The rates of female and male patients were comparable. The investigated patients were mostly young and middle\u2010aged. Most patients suffered from vitiligo in childhood or young adulthood. Vitiligo vulgaris was the most common type of vitiligo in clinic and 53.0% of patients were categorized as body surface area (<jats:styled-content style=\"fixed-case\">BSA<\/jats:styled-content>) of 10% or less. In response to the latest treatment, 43.6% of patients achieved good response (completely stopped or almost disappeared). More patients at active stage showed good response than the patients at stable stage (\u03c7<jats:sup>2<\/jats:sup> = 7.866, <jats:italic>P<\/jats:italic> &lt; 0.05). Chronic comorbid condition(s) were observed in 12.6% of patients with <jats:styled-content style=\"fixed-case\">BSA<\/jats:styled-content> of more than 10%, whereas those were seen in 6.0% of patients with <jats:styled-content style=\"fixed-case\">BSA<\/jats:styled-content> of 10% or less (\u03c7<jats:sup>2<\/jats:sup> = 12.969, <jats:italic>P<\/jats:italic> &lt; 0.05). In conclusion, active vitiligo seems to respond better than stable vitiligo and complications with other autoimmune diseases more frequently observed in severe patients than mild patients. The current study presented a comprehensive understanding of vitiligo in the northeast of China.<\/jats:p>","DOI":"10.1111\/1346-8138.14016","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T04:42:47Z","timestamp":1506141767000},"page":"39-45","source":"Crossref","is-referenced-by-count":3,"title":["Comprehensive survey of vitiligo patients in the northeast of China using a predesigned questionnaire"],"prefix":"10.1111","volume":"45","author":[{"given":"Zheng","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Dermatology No. 1 Hospital of China Medical University Shenyang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Dermatology No. 1 Hospital of Jilin University Changchun China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingxue","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Dermatology No. 2 Hospital of Harbin Medical University Harbin China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology No. 1 Hospital of China Medical University Shenyang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1043-3155","authenticated-orcid":false,"given":"Yan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Dermatology No. 1 Hospital of China Medical University Shenyang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bihuan","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Dermatology No. 1 Hospital of China Medical University Shenyang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-8564","authenticated-orcid":false,"given":"Xing\u2010Hua","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Dermatology No. 1 Hospital of China Medical University Shenyang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong\u2010Duo","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology No. 1 Hospital of China Medical University Shenyang China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,9,22]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0749.2003.00032.x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200102030-00006"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-009-1915-x"},{"key":"e_1_2_7_5_1","first-page":"67","article-title":"Interventions for vitiligo: a Cochrane systematic review","volume":"169","author":"Whitton ME","year":"2006","journal-title":"Br J Dermatol"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-081X(97)00128-4"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061592"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.32708"},{"key":"e_1_2_7_9_1","doi-asserted-by":"crossref","unstructured":"FitzpatrickTB MosherBD OrtonneJP.Disorders of melanocytes[J]. Chapter 2008:138\u2013152.","DOI":"10.3109\/9780203092149-11"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.06.023"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08881.x"},{"key":"e_1_2_7_12_1","first-page":"705","article-title":"Vitiligo: nonsurgicaltreatment options and the evidencebehind their use","volume":"7","author":"Fenton JS","year":"2008","journal-title":"J Drugs Dermatol"},{"volume-title":"Rook's Textbook of Dermatology","year":"2016","author":"Burns T","key":"e_1_2_7_13_1"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.12.1514"},{"key":"e_1_2_7_15_1","first-page":"1","article-title":"Policy decisionmaking and outcomes research in drug utilization","volume":"1","author":"Rychlik R","year":"2005","journal-title":"Z Gesundheitswiss\/J Public Health"},{"key":"e_1_2_7_16_1","first-page":"1861","article-title":"Methods for the comparative evaluation of pharmaceuticals","volume":"1","author":"Zentner A","year":"2005","journal-title":"GMS Health Technol Assess 1"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1159\/000128992"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2011.01377.x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2005.01813.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archderm.1993.01680290066010","article-title":"Pattern of familialaggregation of vitiligo","volume":"129","author":"Majumder PP","year":"1993","journal-title":"Arch Dermatol"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1999.tb02067.x"},{"key":"e_1_2_7_22_1","first-page":"616","volume-title":"Fitzpatrick's Dermatology in General Medicine","author":"Hadler RM","year":"2008"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.45144"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0365-05962004000300010"},{"issue":"3","key":"e_1_2_7_25_1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2009.03.022","article-title":"The burden of vitiligo: patient characteristics associated with quality of life","volume":"61","author":"Linthorst Homan MW","year":"2009","journal-title":"JAMA Dermatol"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2009.03617.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1346-8138.12099","article-title":"Guidelines for the diagnosis and treatment of vitiligo in Japan","volume":"40","author":"Oiso N","year":"2013","journal-title":"J Dermatol"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11095.x"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/207877a0"},{"key":"e_1_2_7_30_1","first-page":"129","article-title":"Clinical characteristics in 113 Turkish vitiligopatients","volume":"17","author":"Arycan O","year":"2008","journal-title":"Acta Dermatovenereol Alp Panonica Adriat"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09091.x"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1346-8138.14016","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1346-8138.14016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T16:21:52Z","timestamp":1695572512000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1346-8138.14016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,22]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1111\/1346-8138.14016"],"URL":"https:\/\/doi.org\/10.1111\/1346-8138.14016","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"type":"print","value":"0385-2407"},{"type":"electronic","value":"1346-8138"}],"subject":[],"published":{"date-parts":[[2017,9,22]]}}}